Latest Diabetes: Type II news
ADA: Once-Weekly Dulaglutide Ups Glycemic Control in Youth With T2D
posted June 7th
by modernClinician Editorial Team
by modernClinician Editorial Team
ADA: Tirzepatide Improves Kidney Outcomes in T2DM With Increased CV Risk
posted June 6th
by modernClinician Editorial Team
by modernClinician Editorial Team
Rate of Major Complications Low With Living Donor Nephrectomy
Risk for Hospitalization for Heart Failure Down With SGLT-2i Treatment for T2D
posted May 24th
by modernClinician Editorial Team
by modernClinician Editorial Team
SGLT2 Inhibitors Reduce Heart Failure Hospitalization
Mounjaro Approved for Blood Glucose Control in Type 2 Diabetes
posted May 20th
by modernClinician Editorial Team
by modernClinician Editorial Team
Skyrizi Approved for Psoriatic Arthritis
Editor's Recommendations
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
Long-Term Medication Adherence Tied to Lower Cardiovascular Event Rate in Type 2 Diabetes 
Add-On Tirzepatide May Reduce MACE Risk in People With T2D, ASCVD 
Type 2 Diabetes Linked to Worse Menopausal Symptoms Related Articles
.jpg)
Semaglutide Not Linked to Higher Neovascular Age-Related Macular Degeneration Risk 
AHA: Consuming Up to 400 mg/Day of Caffeine Safe for Most Adults 
GLP-1 Receptor Agonist Use Linked to Higher Risk for Ischemic Optic Neuropathy Monthly Specialist Briefings
Stay Connected
